Tag: INSPIRE

Two new patients convert in Invivo Therapeutics’ INSPIRE trial

Invivo Therapeutics has provided an update on the progress of the company’s INSPIRE study (Invivo Study of Probable Benefit of the Neuro-Spinal Scaffold for...

UCHealth Memorial Hospital new site for InVivo Therapeutics’ INSPIRE study

InVivo Therapeutics hasannounced that the UCHealth Memorial Hospital in Colorado Springs, USA has been added as a clinical site for the INSPIRE study (InVivo...

New patient enrolled in InVivo Therapeutics’ INSPIRE study

InVivo Therapeutics has announced that a new patient has been enrolled into the INSPIRE study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold...

New patient enrolled in InVivo Therapeutics INSPIRE study

A new patient has been enrolled into InVivo Therapeutics' INSPIRE study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold for Safety and Neurologic...

InVivo to include international registry data in sister study to INSPIRE

InVivo Therapeutics has announced that data from the Christopher & Dana Reeve Foundation NACTN Registry will be included in the Contemporary Thoracic SCI registry...

New patient enrolled in InVivo INSPIRE study

A new patient has been enrolled into InVivo Therapeutics’ INSPIRE Study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold for Safety and Neurologic...

InVivo Therapeutics announces first Canadian site for cervical spinal cord injury...

InVivo Therapeutics has received approval from the Toronto Western Hospital’s Research Ethics Board to enrol patients as part of its cervical spinal cord injury...

Seventh InVivo Therapeutics INSPIRE patient converts AIS grade

InVivo Therapeutics has announced that the patient enrolled in January in the INSPIRE study of the Neuro-spinal scaffold has improved from a complete AIS...

InVivo Therapeutics enrols Keck Hospital patient into INSPIRE study

A new patient has been enrolled into InVivo Therapeutics’ INSPIRE study (InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold for Safety and Neurologic...

Sixth INSPIRE patient improves ASIA score

An Invivo Therapeutics INSPIRE study patient enrolled in December 2016 has improved from a complete ASIA A spinal cord injury to an incomplete ASIA...

New patient enrolled into Invivo Therapeutics INSPIRE study

A new patient has been enrolled into Invivo Therapeutics’ INSPIRE Study (InVivo Study of Probable Benefit of the Neuro-spinal scaffold for Safety and Neurologic...

New Mexico Hospital joins Invivo’s INSPIRE study

The University of New Mexico Hospital (UNMH) in Albuquerque, USA, has been added as a clinical site for the INSPIRE (Invivo Study of Probable...

Rhode Island Hospital joins InVivo’s INSPIRE study

InVivo Therapeutics has announced that Rhode Island Hospital in Providence, USA, has been added as a clinical site for the INSPIRE (InVivo Study of...

Tenth patient enrolled in InVivo Therapeutics’ INSPIRE study

A new patient with a T8-9 fracture dislocation injury has been enrolled into InVivo Therapeutics’ INSPIRE Study (InVivo Study of Probable Benefit of the...

Beth Israel Deaconess Medical Center joins Invivo Therapeutics’ INSPIRE study

Beth Israel Deaconess Medical Center in Boston, USA has been added as a clinical site for the INSPIRE study (InVivo Study of Probable Benefit...

Calgary centre added as new Canadian InVivo Therapeutics INSPIRE study site

The Foothills Medical Centre in Calgary has been added as a Canadian clinical site for InVivo Therapeutics’ INSPIRE study (InVivo Study of Probable Benefit...

Fifth INSPIRE study patient improves, Northwestern Medicine added as clinical site

The ninth spinal cord injury patient in the INSPIRE trial—implanted with InVivo Therapeutics’ neuro-spinal scaffold last month—is showing signs of improvement. The patient is...